Prospective identification of tumorigenic prostate cancer stem cells.

By A. Collins, P. Berry, Catherine Hyde, M. Stower, N. Maitland. Cancer Research, 2005

2,922 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2b6e2f3cb136c9007900213755c1e60a5ebff8ec

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Oncology

Citations in the corpus

Genetics and biology of pancreatic ductal adenocarcinoma. (2006, background): “…cells have also been described in solid organs, including cancer of the breast, brain, and prostate (Al-Hajj et al. 2003; Singh et al. 2004b; Collins et al. 2005), and candi- 1232 GENES & DEVELOPMENT dates have been found in lung neoplasia and melanoma (Fang et al. 2005; C.F. Kim et al.…”
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma (2011, background): “CD44 is a cell surface marker that has been shown to be highly expressed in putative head and neck cancer stem cells [196-200].”
Oxidative stress, inflammation, and cancer: how are they linked? (2010, background): “The first conclusive evidence for CSCs was published in 1997 [286], and to date CSCs have been isolated from both leukemias and a variety of solid tumors, including breast, brain, pancreatic, prostrate, ovary, and colon cancers [287-293].”
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells (2008, background): “Whereas brain tumor and colon cancer stem cells have been reported to be CD133 positive, tumor stem cells from other cancers may express different markers such as CD34(1)/CD38(2) for acute myeloid leukaemia,(3,4,37) CD44(1)/CD24(2) for breast tumors,(6) Sca-1(1)/CD45(2)/PECAM(2)/ CD34(1) for adenoca”
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (2008, background): “Other studies have identified putative human prostate CSCs with a CD44 + α2 integrin + β1 integrin hi CD133 + phenotype based on extensive proliferative capacity in vitro”
Cancer stem cells: an old idea--a paradigm shift. (2006, background): “1% of total tumor cells formed tumors in NOD/SCID mice, whereas 5 10(5) CD44 cells failed to form tumors (38).”
The biology of cancer stem cells. (2007, background): “The CD44 + /α 2 β 1 hi /CD133 + population from both primary and metastatic prostate tumors contained an enriched capacity for tumorigenic properties in vitro (Collins et al. 2005).”
Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis (2015, neutral): “, 2000) and has been linked to cancer stem cells in multiple cancer types (Collins et al., 2005; O’Brien et al., 2007).”